Neuroblastoma Global Clinical Trials Review, H1, 2014 - KAIT-Jonesboro, AR-News, weather, sports

Neuroblastoma Global Clinical Trials Review, H1, 2014

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE ReportBuyer



 

 

 

LONDON, June 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Neuroblastoma Global Clinical Trials Review, H1, 2014

http://www.reportbuyer.com/pharma_healthcare/drug_discovery/neuroblastoma_global_clinical_trials_review_h1_2014.html

Neuroblastoma Global Clinical Trials Review, H1, 2014


Summary

GlobalData's clinical trial report, "Neuroblastoma Global Clinical Trials Review, H1, 2014" provides data on the Neuroblastoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuroblastoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neuroblastoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)


Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction 6
Neuroblastoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Neuroblastoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Neuroblastoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Neuroblastoma 24
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Neuroblastoma Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Neuroblastoma 34
Aug 13, 2013: Cancer Research UK launches international trial for treatment of relapsed neuroblastoma 34
Jun 21, 2012: Aeterna Zentaris Announces Phase I Results Of Perifosine Show Activity Against Neuroblastoma 34
Jun 21, 2012: Cleveland BioLabs And Incuron Announce Results Of Studies Of CBL0137 In Animal Models Of Neuroblastoma 35
Jun 13, 2012: Aeterna Zentaris To Present Phase I Results Of Perifosine In Neuroblastoma At Upcoming Neuroblastoma Research Conference 36
Jun 12, 2012: Study Unveils Combination Of Radioactive Isotope With Chemotherapy Has Potential To Treat 36
Neuroblastoma 36
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
Progenics Pharmaceuticals, Inc. 38
Clinical Trial Overview of Progenics Pharmaceuticals, Inc. 38
F. Hoffmann-La Roche Ltd. 39
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 39
APEIRON Biologics AG 40
Clinical Trial Overview of APEIRON Biologics AG 40
United Therapeutics Corporation 41
Clinical Trial Overview of United Therapeutics Corporation 41
Cancer Prevention Pharmaceuticals, Inc. 42
Clinical Trial Overview of Cancer Prevention Pharmaceuticals, Inc. 42
MabVax Therapeutics, Inc. 43
Clinical Trial Overview of MabVax Therapeutics, Inc. 43
Eli Lilly and Company 44
Clinical Trial Overview of Eli Lilly and Company 44
Celgene Corporation 45
Clinical Trial Overview of Celgene Corporation 45
Biotec Pharmacon ASA 46
Clinical Trial Overview of Biotec Pharmacon ASA 46
Clinical Trial Overview of Top Institutes / Government 47
National Cancer Institute 47
Clinical Trial Overview of National Cancer Institute 47
Children's Oncology Group 53
Clinical Trial Overview of Children's Oncology Group 53
Memorial Sloan Kettering Cancer Center 56
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 56
Children's Cancer and Leukaemia Group 59
Clinical Trial Overview of Children's Cancer and Leukaemia Group 59
Baylor College of Medicine 61
Clinical Trial Overview of Baylor College of Medicine 61
Fred Hutchinson Cancer Research Center 62
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 62
New Approaches to Neuroblastoma Therapy 63
Clinical Trial Overview of New Approaches to Neuroblastoma Therapy 63
The Children's Hospital Los Angeles 64
Clinical Trial Overview of The Children's Hospital Los Angeles 64
Japan Neuroblastoma study group 65
Clinical Trial Overview of Japan Neuroblastoma study group 65
Five Key Clinical Profiles 66
Appendix 144
Abbreviations 144
Definitions 144
Research Methodology 145
Secondary Research 145
About GlobalData 146
Contact Us 146
Disclaimer 146
Source 147


List of Tables

Neuroblastoma Therapeutics, Global, Clinical Trials by Region, 2014* 7
Neuroblastoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Neuroblastoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Neuroblastoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Neuroblastoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Neuroblastoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Neuroblastoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Neuroblastoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Neuroblastoma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Neuroblastoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Neuroblastoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Neuroblastoma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Neuroblastoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Neuroblastoma Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Neuroblastoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Neuroblastoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Neuroblastoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Neuroblastoma Therapeutics, Global, Suspended Clinical Trials, 2014* 24
Neuroblastoma Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Neuroblastoma Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Neuroblastoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Neuroblastoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Neuroblastoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Neuroblastoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Neuroblastoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Progenics Pharmaceuticals, Inc., 2014* 38
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 39
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by APEIRON Biologics AG, 2014* 40
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2014* 41
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Prevention Pharmaceuticals, Inc., 2014* 42
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by MabVax Therapeutics, Inc., 2014* 43
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 44
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014* 45
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotec Pharmacon ASA, 2014* 46
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 47
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 53
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 56
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Cancer and Leukaemia Group, 2014* 59
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2014* 61
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 62
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by New Approaches to Neuroblastoma Therapy, 2014* 63
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital Los Angeles, 2014* 64
Neuroblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Neuroblastoma study group, 2014* 65


List of Figures

Neuroblastoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Neuroblastoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Neuroblastoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Neuroblastoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Neuroblastoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Neuroblastoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Neuroblastoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Neuroblastoma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Neuroblastoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Neuroblastoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Neuroblastoma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Neuroblastoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Neuroblastoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Neuroblastoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Neuroblastoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Neuroblastoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Neuroblastoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Neuroblastoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Neuroblastoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Neuroblastoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 145



Read the full report:
Neuroblastoma Global Clinical Trials Review, H1, 2014

http://www.reportbuyer.com/pharma_healthcare/drug_discovery/neuroblastoma_global_clinical_trials_review_h1_2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

472 Craighead Co. 766
Jonesboro, AR 72401
(870) 931-8888

FCC Public File
publicfile@kait8.com
(870) 336-1816
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KAIT. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.